Publications

5674 Results

Report on workshop regarding leukemia studies by SWOG cytogenetic laboratories.

Authors
G Kinzie
Journal / Conference
The Journal of the Association of Genetic Technologists 24(2):44-46
Year
1998
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9007

Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246.

Authors
OW Press;M LeBlanc;TJ O'Rourke;S Gagnet;RA Chapman;SP Balcerzak;RI Fisher
Journal / Conference
Journal of Clinical Oncology 16(2):574-578
Year
1998
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9246

Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials.

Authors
LE Flaherty;JM Unger;PY Liu;WC Mertens;VK Sondak
Journal / Conference
American Journal of Clinical Oncology 21(6):568-572
Year
1998
Research Committee(s)
Melanoma

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study.

Authors
AJ Wozniak;JJ Crowley;SP Balcerzak;GR Weiss;CH Spiridonidis;LH Baker;KS Albain;K Kelly;SA Taylor;DR Gandara;RB Livingston
Journal / Conference
Journal of Clinical Oncology 16(7):2459-2465
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-9308

Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: A Southwest Oncology Group study.

Authors
DJ Ahnen;P Feigl;G Quan;C Fenoglio-Preiser;LC Lovato;PA Bunn Jr;G Stemmermann;JD Wells;JS Macdonald;FL Meyskens Jr
Journal / Conference
Cancer Research 58:1149-1158
Year
1998
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9000

Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: A phase II study of the Southwest Oncology Group (SWOG-9229).

Authors
CR Thomas Jr;DJ Giroux;KJ Stelzer;JB Craig;LR Laufman;SA Taylor;JW Goodwin;JJ Crowley;RB Livingtson
Journal / Conference
Int J Radiat Oncol Biol Phys 40(5):1039-1047
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-9229

Heat shock proteins hsp27 and hsp70: Lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer: (A Southwest Oncology Group study).

Authors
DR Ciocca;S Green;RM Elledge;GM Clark;R Pugh;P Ravdin;D Lew;S Martino;CK Osborne
Journal / Conference
Clinical Cancer Research 5:1263-1266
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-9314

Heat shock proteins hsp27 and hsp70 are not associated with clinical resistance to tamoxifen in breast cancer: A Southwest Oncology Group study.

Authors
D Ciocca;S Green;R Elledge;G Clark;R Pugh;P Ravdin;D Lew;S Martino;CK Osborne
Journal / Conference
Proc of the American Association for Cancer Research 39:229(#1568)
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-9314

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high grade non-hodgkin's lymphoma.

Authors
TP Miller;S Dahlberg;JR Cassady;DJ Adelstein;CM Spier;TM Grogan;M LeBlanc;S Carlin;E Chase;RI Fisher
Journal / Conference
New England Journal of Medicine 339:21-26
Year
1998
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8736 (INT-0093)

Army and Air Force leadership in the prostate cancer prevention trial.

Authors
J Allerton;T Seay;S Optenberg;CA Coltman Jr;B Higgins;I Thompson;L Lovato
Journal / Conference
Urology 51(Suppl.4A):64-66
Year
1998
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217